Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.
MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.
Avian Pathol. 2023 Oct;52(5):377-387. doi: 10.1080/03079457.2023.2239191. Epub 2023 Aug 15.
H9N2 subtype of avian influenza virus (AIV) is primarily a bird virus, which is widespread in clinical avian disease, and reported in cases of human infection. As one of the surface proteins of AIV, the neuraminidase (NA) protein plays an important role mainly in viral budding. However, vaccine development and detection methods for NA of H9N2 AIVs are in urgent clinical need. In this study, a truncated NA gene (205-900 bp) was cloned from the NA sequence of H9N2 strain, and then expressed using pET-28a (+) vector. This purified recombinant NA protein was used to immunize BALB/c mice, and the monoclonal antibodies were screened through the indirect enzyme-linked immunosorbent assay (ELISA). Next, eight prokaryotic expression vectors were constructed for epitope identification. After cell fusion, three hybridoma cell lines producing the antibodies special to NA protein were screened by ELISA, western blotting, and indirect immunofluorescence; these were named 1B10, 2B6, and 5B2, respectively. Epitope scanning techniques were used to identify three B-cell epitopes recognized by these three monoclonal antibodies, KNATASIIYDGMLVD, DSIGSWSKNIL and RTQESECVCI. The subsequent homology analysis revealed the three epitopes were highly conserved in H9N2 AIV strains. The structural predictions of the antigenic epitopes indicated that all three epitopes were located in the catalytic region of NA. These results provide a basis for studying the function of the NA protein of H9N2 AIV and technical support for the development of a universal detection method based on anti-NA monoclonal antibodies.
H9N2 亚型禽流感病毒(AIV)主要是一种禽病毒,广泛存在于临床禽病中,并报告了人类感染病例。作为 AIV 的表面蛋白之一,神经氨酸酶(NA)蛋白主要在病毒出芽中发挥重要作用。然而,H9N2 AIV 的 NA 疫苗开发和检测方法在临床上非常需要。本研究从 H9N2 株的 NA 序列中克隆了一个截断的 NA 基因(205-900bp),并使用 pET-28a(+)载体进行表达。该纯化的重组 NA 蛋白用于免疫 BALB/c 小鼠,并通过间接酶联免疫吸附试验(ELISA)筛选单克隆抗体。然后,构建了 8 个原核表达载体用于表位鉴定。细胞融合后,通过 ELISA、western blot 和间接免疫荧光筛选出 3 株针对 NA 蛋白的杂交瘤细胞系,分别命名为 1B10、2B6 和 5B2。通过表位扫描技术鉴定了这 3 株单抗识别的 3 个 B 细胞表位,分别为 KNATASIIYDGMLVD、DSIGSWSKNIL 和 RTQESECVCI。随后的同源性分析表明,这 3 个表位在 H9N2 AIV 株中高度保守。抗原表位的结构预测表明,这 3 个表位均位于 NA 的催化区域。这些结果为研究 H9N2 AIV 的 NA 蛋白功能提供了依据,也为基于抗-NA 单克隆抗体的通用检测方法的开发提供了技术支持。